Fulgent Genetics Inc
FLGT
Get informed when a big investor buys or sells
+ FollowMarket Cap$583.63M
Close$
$7.59
63.9% downside
Current Fair Value
63.9% downsideOvervalued by 63.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $583.63 Million |
|---|---|
| Enterprise Value | $573.41 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.97 |
| Beta | 0.89 |
| Outstanding Shares | 30,881,000 |
Return
| Return on Equity | -7.03% |
|---|---|
| Return on Assets | -6.38% |
| Return on Invested Capital | -8.55% |
Valuation & Multiples
| P/E Ratio | -8.63 |
|---|---|
| PEG | -7.49 |
| Price to Sales | 2.1 |
| Price to Book Ratio | 0.64 |
| Enterprise Value to Revenue | 1.79 |
| Enterprise Value to EBIT | -6.29 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 1, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
$68.09 M
Average shareholder expectationNext Earnings Call
Expected Date
July 30, 2026
EPS Estimate
$-0.46
Average shareholder expectationRevenue Estimate
$94.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 41.54% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.46%▼ 56.24% |
|---|---|
| Total Invested | $2.94M▼ 98.94% |
| Investors Holding | 6▼ 155.00% |
ESG Score
No data
About Fulgent Genetics Inc
429 employees
CEO: Ming Hsieh Fulgent Genetics' proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy and...